J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)
Goldman Sachs Initiates Sanofi(SNY.US) With Hold Rating, Announces Target Price $65
Goldman Sachs Initiates Coverage On Sanofi With Neutral Rating, Announces Price Target of $65
Sanofi Analyst Ratings
Goldman Sachs Upgrades Sanofi (SNYNF) to a Hold
Bernstein Keeps Their Buy Rating on Sanofi (SNYNF)
Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), Sanofi (SNYNF)
Berenberg Ups Sanofi Price Target Amid 'Highly Attractive' Valuation, Shareholder Alignment
Berenberg Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
Berenberg Bank Maintains Sanofi(SNY.US) With Buy Rating, Maintains Target Price $63
Deutsche Bank Remains a Hold on Sanofi (SNYNF)
Sanofi's Sustained Revenue Growth Potential: Buy Rating Justified by Extended Amvuttra Royalties
Sanofi Target Raised to EUR125 From EUR100 by Intron Health
Sanofi Raised to Buy From Hold by Intron Health
Sanofi (SNYNF) Receives a Buy From Bernstein
Sanofi (SNYNF) Gets a Buy From UBS
DBS Maintains Sanofi(SNY.US) With Buy Rating, Announces Target Price $64
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Boston Scientific (BSX) and Sanofi (OtherSNYNF)
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Unlock the Full List